Immuneering Corp
IMRX· Nasdaq
IMRXImmuneering Corp
Filed Nov 10, 2022 · 10-Q · 41 days after period end · 0001558370-22-017304
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $38.38K | $482.13K | $682.57K |
| Net Income | -$12.84M | -$8.53M | -$4.40M |
| EPS Diluted | -$0.49 | -$0.47 | -$0.89 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immuneering Corp · CIK 1790340 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 10, 2022 · 41 d after period end
